These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity. Bonomi A; Coccè V; Cavicchini L; Sisto F; Dossena M; Balzarini P; Portolani N; Ciusani E; Parati E; Alessandri G; Pessina A Int J Immunopathol Pharmacol; 2013; 26(1 Suppl):33-41. PubMed ID: 24046947 [TBL] [Abstract][Full Text] [Related]
5. Fluorescent Immortalized Human Adipose Derived Stromal Cells (hASCs-TS/GFP+) for Studying Cell Drug Delivery Mediated by Microvesicles. Cocce V; Balducci L; Falchetti ML; Pascucci L; Ciusani E; Brini AT; Sisto F; Piovani G; Alessandri G; Parati E; Cabeza L; Pessina A Anticancer Agents Med Chem; 2017 Nov; 17(11):1578-1585. PubMed ID: 28356007 [TBL] [Abstract][Full Text] [Related]
6. Paclitaxel Priming of TRAIL Expressing Mesenchymal Stromal Cells (MSCs-TRAIL) Increases Antitumor Efficacy of Their Secretome. Coccè V; Bonomi A; Cavicchini L; Sisto F; Giannì A; Farronato G; Alessandri G; Petrella F; Sordi V; Parati E; Bondiolotti G; Paino F; Pessina A Curr Cancer Drug Targets; 2020 Nov; ():. PubMed ID: 33200709 [TBL] [Abstract][Full Text] [Related]
7. Synergistic Chemo-Photothermal Therapy of Breast Cancer by Mesenchymal Stem Cell-Encapsulated Yolk-Shell GNR@HPMO-PTX Nanospheres. Wu J; Liu Y; Tang Y; Wang S; Wang C; Li Y; Su X; Tian J; Tian Y; Pan J; Su Y; Zhu H; Teng Z; Lu G ACS Appl Mater Interfaces; 2016 Jul; 8(28):17927-35. PubMed ID: 27356586 [TBL] [Abstract][Full Text] [Related]
8. Adipose tissue-derived mesenchymal stromal cells for clinical application: An efficient isolation approach. Lisini D; Nava S; Pogliani S; Avanzini MA; Lenta E; Bedini G; Mantelli M; Pecciarini L; Croce S; Boncoraglio G; Maccario R; Parati EA; Frigerio S Curr Res Transl Med; 2019 Feb; 67(1):20-27. PubMed ID: 30104160 [TBL] [Abstract][Full Text] [Related]
9. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. Pascucci L; Coccè V; Bonomi A; Ami D; Ceccarelli P; Ciusani E; Viganò L; Locatelli A; Sisto F; Doglia SM; Parati E; Bernardo ME; Muraca M; Alessandri G; Bondiolotti G; Pessina A J Control Release; 2014 Oct; 192():262-70. PubMed ID: 25084218 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-releasing mesenchymal stromal cells inhibit the growth of multiple myeloma cells in a dynamic 3D culture system. Bonomi A; Steimberg N; Benetti A; Berenzi A; Alessandri G; Pascucci L; Boniotti J; Coccè V; Sordi V; Pessina A; Mazzoleni G Hematol Oncol; 2017 Dec; 35(4):693-702. PubMed ID: 27283119 [TBL] [Abstract][Full Text] [Related]
11. Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study. Bonomi A; Silini A; Vertua E; Signoroni PB; Coccè V; Cavicchini L; Sisto F; Alessandri G; Pessina A; Parolini O Stem Cell Res Ther; 2015 Aug; 6(1):155. PubMed ID: 26315881 [TBL] [Abstract][Full Text] [Related]